Edition:
United States

ConforMIS Inc (CFMS.OQ)

CFMS.OQ on NASDAQ Stock Exchange Global Select Market

0.92USD
20 Aug 2018
Change (% chg)

$0.01 (+1.37%)
Prev Close
$0.91
Open
$0.92
Day's High
$0.94
Day's Low
$0.88
Volume
28,811
Avg. Vol
112,606
52-wk High
$4.15
52-wk Low
$0.88

Latest Key Developments (Source: Significant Developments)

Conformis Q4 Loss Per Share $0.27
Wednesday, 7 Feb 2018 04:05pm EST 

Feb 7 (Reuters) - Conformis Inc ::CONFORMIS REPORTS FOURTH QUARTER AND THE YEAR ENDED 2017 FINANCIAL RESULTS; REITERATES 2018 FINANCIAL GUIDANCE.Q4 LOSS PER SHARE $0.27.Q4 REVENUE $20.8 MILLION.SEES QUARTERLY REVENUE $19.1 MILLION TO $19.8 MILLION.SEES FY 2018 REVENUE $79.6 MILLION TO $83.6 MILLION.FOR Q1 OF 2018, COMPANY IS ALSO PROVIDING QUARTERLY GUIDANCE OF TOTAL REVENUE IN A RANGE OF $19.1 MILLION TO $19.8 MILLION.FOR FULL YEAR 2018, COMPANY EXPECTS TOTAL GROSS MARGIN IN A RANGE OF 44% TO 46%.Q4 EARNINGS PER SHARE VIEW $-0.30, REVENUE VIEW $20.2 MILLION -- THOMSON REUTERS I/B/E/S.FY2018 REVENUE VIEW $83.1 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Conformis Announces Pricing Of Public Offering Of Common Stock
Thursday, 25 Jan 2018 08:00am EST 

Jan 25 (Reuters) - Conformis Inc ::CONFORMIS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.CONFORMIS INC - PRICED UNDERWRITTEN PUBLIC OFFERING OF 13.3 MILLION SHARES OF COMMON STOCK AT $1.50/SHARE​.  Full Article

Conformis - Expects Gross Profit Of About $28.8 Mln For Year Ended Dec 31, 2017
Wednesday, 24 Jan 2018 05:40pm EST 

Jan 24 (Reuters) - Conformis Inc ::CONFORMIS - GROSS PROFIT EXPECTED TO BE ABOUT $28.8 MILLION OR ABOUT 37% OF REVENUE, FOR YEAR ENDED DECEMBER 31, 2017-SEC FILING.CONFORMIS - ANNOUNCES THAT IT EXPECTS GROSS MARGIN FOR QUARTER ENDED DECEMBER 31, 2017 TO BE ABOUT 42 PERCENT.CONFORMIS-CO'S CASH, CASH EQUIVALENTS, INVESTMENTS AS OF DEC 31 2017 ARE PROJECTED TO BE ABOUT $45.2 MILLION , AS COMPARED TO $65.5 MILLION AS OF DEC 31 2016.  Full Article

ConforMIS Sees FY 2018 Revenue $79.6 Mln To $83.6 Mln
Monday, 8 Jan 2018 04:15pm EST 

Jan 8 (Reuters) - ConforMIS Inc ::SEES ‍Q4 TOTAL REVENUE OF ABOUT $20.8 MILLION, DOWN 4% YEAR-OVER-YEAR ON A REPORTED BASIS​.CONFORMIS REPORTS PRELIMINARY FOURTH QUARTER AND YEAR-END 2017 REVENUE RESULTS; PROVIDES 2018 FINANCIAL GUIDANCE.SEES FY 2018 REVENUE $79.6 MILLION TO $83.6 MILLION.SEES 2017 TOTAL REVENUE OF APPROXIMATELY $78.1 MILLION, DOWN 2% YEAR-OVER-YEAR.FY2017 REVENUE VIEW $77.3 MILLION -- THOMSON REUTERS I/B/E/S.FY2018 REVENUE VIEW $84.2 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Conformis Q3 loss per share $0.29
Wednesday, 1 Nov 2017 04:05pm EDT 

Nov 1 (Reuters) - Conformis Inc ::Conformis reports third quarter 2017 financial results.Q3 loss per share $0.29.Q3 revenue $18.4 million versus I/B/E/S view $17.6 million.Q3 earnings per share view $-0.31 -- Thomson Reuters I/B/E/S.  Full Article

Conformis Inc acquires machining and polishing assets from Broad Peak
Wednesday, 9 Aug 2017 07:00am EDT 

Aug 9 (Reuters) - Conformis Inc ::Conformis inc - ‍purchase price for machining and polishing assets is approximately $6.5 million​.Conformis acquires machining and polishing assets from Broad Peak Manufacturing.Conformis inc - ‍purchase price consisting of $5.75 million in cash and approximately $0.75 million in common stock​.Says ‍under terms of agreement, Conformis will lease manufacturing facility in Wallingford, CT​.Conformis - ‍will lease manufacturing facility in Wallingford, CT, and about twenty Broad Peak Machining and polishing personnel will join co's team​.Says about twenty Broad Peak Machining and polishing personnel will join Conformis Team​.  Full Article

Conformis reports Q2 loss per share $0.28
Thursday, 3 Aug 2017 04:05pm EDT 

Aug 3 (Reuters) - Conformis Inc :Conformis reports second quarter 2017 financial results and updates fiscal year 2017 guidance.Q2 loss per share $0.28.Q2 revenue $18.5 million versus I/B/E/S view $19.4 million.Q2 earnings per share view $-0.36 -- Thomson Reuters I/B/E/S.Sees FY 2017 revenue $75 million to $78 million.Conformis Inc - for full year 2017, company expects gross margin in a range of 34 pct to 36 pct.Conformis Inc sees full year 2017 product revenue in a range of $74 million to $77 million.FY2017 revenue view $82.9 million -- Thomson Reuters I/B/E/S.  Full Article

Conformis announces FDA 510(k) clearance for itotal hip system
Tuesday, 20 Jun 2017 08:00am EDT 

June 20 (Reuters) - Conformis Inc :Conformis announces FDA 510(k) clearance for itotal hip system.Conformis - expect to leverage synergies with sales representatives, surgeons, hospitals upon limited launch of itotal hip replacement system, which is anticipated for 2019.  Full Article

ConforMIS reports Q1 revenue $20.5 million
Wednesday, 10 May 2017 04:05pm EDT 

May 10 (Reuters) - ConforMIS Inc :ConforMIS reports first quarter 2017 financial results.Q1 loss per share $0.40.Q1 revenue $20.5 million versus I/B/E/S view $18.4 million.Sees FY 2017 revenue $80 million to $84 million.Q1 earnings per share view $-0.37 -- Thomson Reuters I/B/E/S.ConforMIS Inc - Full year guidance remains unchanged.FY2017 earnings per share view $-1.39, revenue view $82.1 million -- Thomson Reuters I/B/E/S.  Full Article

Conformis announces positive results from customized iTotal PS total knee replacement comparative study
Wednesday, 12 Apr 2017 09:09am EDT 

Conformis Inc : Conformis announces positive results from customized itotal ps total knee replacement comparative study . Conformis Inc - "in its first year of release itotal ps has met our expectations in terms of surgeon adoption and patient outcomes" .Conformis - study suggests iTotal PS has kinematic, functional benefits have been demonstrated with iTotal CR compared with traditional, off-shelf implants.  Full Article

BRIEF-Conformis Inc Q1 Loss Per Share $0.22

* Q1 EARNINGS PER SHARE VIEW $-0.25 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: